The results of this study emphasized the importance of the combined detection of serum AFP, AFP-L3% and PIVKA-II in the diagnosis of liver cancers and provided clearer guidance on the selection of hematological diagnostic methods for liver cancers. The gene discussed is AFP; the disease is liver cancer.